While the selected cell lines may not be a complete representation of KMT2A-r and KMT2A-w ALL, it is important to note that this approach successfully pinpointed well-established vulnerabilities specific to KMT2A-r ALL, such as CREBBP, PSIP1, and FLT3. This evidence concerns the gene CREBBP and acute lymphoblastic leukemia.